NovoCure (NVCR) Receivables (2014 - 2026)
NovoCure's Receivables came in at $106.8 million for Q2 2026, up 10.3% from $96.86 million a year earlier and up 5.2% from the prior quarter.
Analysis
NovoCure (NVCR) Receivables (2014 - 2026) Analysis & Trends
At the end of FY2025, NovoCure's Receivables was $97.22 million, up 21.6% from FY2024.
- Receivables carries a five-year compound annual growth rate of 0.1% (FY2020 to FY2025).
- Going back by year, Receivables was $79.95 million in FY2024 (+22.1%), $65.47 million in FY2023 (-26.0%), $88.45 million in FY2022 (-5.5%) and $93.57 million in FY2021 (-3.2%).
- The Q2 2026 figure represents the highest quarterly Receivables in data going back to Q4 2014.
- Year-over-year, Receivables has increased for eight consecutive quarters, with growth averaging 21.8% over the last eight quarters.
- The fastest year-over-year change in Receivables over five years came in Q2 2025 (growth of 39.3%), and the weakest in Q2 2023 (a decline of 27.2%).
- Business Quant data shows NVCR's Receivables at $101.52 million (Q1 2026), $97.22 million (Q4 2025) and $92.48 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 251.30 Bn | 230.45 Bn | 4.88 Bn | 11.14 Bn |
| 2 | Abbott Laboratories | 174.70 Bn | 145.78 Bn | 7.27 Bn | 8.60 Bn |
| 3 | Danaher | 158.94 Bn | 142.76 Bn | 3.61 Bn | 3.97 Bn |
| 4 | Intuitive Surgical | 145.87 Bn | 125.42 Bn | 1.96 Bn | 1.67 Bn |
| 5 | Medtronic | 111.49 Bn | 77.36 Bn | 6.34 Bn | 6.36 Bn |
| 6 | Stryker | 106.96 Bn | 93.08 Bn | 4.50 Bn | 3.74 Bn |
| 7 | Boston Scientific | 63.62 Bn | 58.63 Bn | 3.85 Bn | 3.05 Bn |
| 8 | Edwards Lifesciences | 50.80 Bn | 34.92 Bn | 1.35 Bn | 955.70 Mn |
| 9 | Becton Dickinson | 49.59 Bn | 46.74 Bn | 2.32 Bn | 2.36 Bn |
| 10 | NovoCure | 1.86 Bn | -491.82 Mn | 142.48 Mn | 106.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 106.80 Mn |
| Mar 31, 2026 | 101.52 Mn |
| Dec 31, 2025 | 97.22 Mn |
| Sep 30, 2025 | 92.48 Mn |
| Jun 30, 2025 | 96.86 Mn |
| Mar 31, 2025 | 91.07 Mn |
| Dec 31, 2024 | 79.95 Mn |
| Sep 30, 2024 | 72.80 Mn |
| Jun 30, 2024 | 69.54 Mn |
| Mar 31, 2024 | 69.78 Mn |
| Dec 31, 2023 | 65.47 Mn |
| Sep 30, 2023 | 65.13 Mn |
| Jun 30, 2023 | 70.99 Mn |
| Mar 31, 2023 | 74.83 Mn |
| Dec 31, 2022 | 88.45 Mn |
| Sep 30, 2022 | 87.55 Mn |
| Jun 30, 2022 | 97.56 Mn |
| Mar 31, 2022 | 100.97 Mn |
| Dec 31, 2021 | 93.57 Mn |
| Sep 30, 2021 | 94.13 Mn |
API Access
NovoCure Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=NVCR&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "NVCR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=NVCR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();